Takeda Pharmaceutical Company Limited
TKPHF
$34.39
-$1.61-4.47%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.18B | 4.60B | 2.43B | 2.57B | 3.14B |
| Total Receivables | 4.83B | 4.75B | 4.71B | 4.84B | 4.68B |
| Inventory | 8.98B | 8.78B | 8.60B | 8.13B | 7.93B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.89B | 1.60B | 1.68B | 1.29B | 1.77B |
| Total Current Assets | 19.88B | 19.74B | 17.42B | 16.84B | 17.52B |
|
|
|||||
| Total Current Assets | 19.88B | 19.74B | 17.42B | 16.84B | 17.52B |
| Net Property, Plant & Equipment | 13.29B | 13.41B | 13.56B | 13.14B | 12.83B |
| Long-term Investments | 36.69B | 36.70B | 36.71B | 35.56B | 35.12B |
| Goodwill | 36.69B | 36.70B | 36.71B | 35.56B | 35.12B |
| Total Other Intangibles | 22.42B | 22.29B | 23.72B | 24.25B | 25.14B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.93B | 5.58B | 5.59B | 5.29B | 5.39B |
| Total Assets | 98.28B | 97.78B | 97.07B | 95.15B | 96.09B |
|
|
|||||
| Total Accounts Payable | 2.98B | 2.97B | 2.92B | 2.06B | 2.93B |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 2.05B | 2.30B | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.72B | 1.99B | 520.14M | 1.79B | 861.64M |
| Total Finance Division Other Current Liabilities | 9.95B | 9.51B | 9.55B | 10.58B | 9.56B |
| Total Other Current Liabilities | 9.95B | 9.51B | 9.55B | 10.58B | 9.56B |
| Total Current Liabilities | 16.65B | 14.46B | 15.04B | 16.74B | 13.34B |
|
|
|||||
| Total Current Liabilities | 16.65B | 14.46B | 15.04B | 16.74B | 13.34B |
| Long-Term Debt | 27.24B | 29.40B | 28.66B | 26.49B | 29.92B |
| Short-term Debt | -- | -- | 2.05B | 2.30B | -- |
| Capital Leases | 3.63B | 3.69B | 3.71B | 3.40B | 3.76B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.01B | 2.04B | 2.07B | 2.21B | 1.87B |
| Total Liabilities | 49.52B | 49.59B | 49.48B | 48.83B | 48.90B |
|
|
|||||
| Common Stock & APIC | 21.98B | 23.17B | 24.16B | 23.17B | 21.95B |
| Retained Earnings | 6.99B | 7.76B | 8.02B | 7.93B | 8.21B |
| Treasury Stock & Other | 19.78B | 17.25B | 15.41B | 15.21B | 17.02B |
| Total Common Equity | 48.75B | 48.18B | 47.58B | 46.31B | 47.18B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.75B | 48.18B | 47.58B | 46.31B | 47.18B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 7.32M | 6.70M | 6.38M | 5.98M | 5.83M |
| Total Equity | 48.75B | 48.19B | 47.59B | 46.32B | 47.19B |
|
|
|||||